Influenza C virus NS1 protein upregulates the splicing of viral mRNAs. 2010

Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
Department of Infectious Diseases, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.

Pre-mRNAs of the influenza A virus M and NS genes are poorly spliced in virus-infected cells. By contrast, in influenza C virus-infected cells, the predominant transcript from the M gene is spliced mRNA. The present study was performed to investigate the mechanism by which influenza C virus M gene-specific mRNA (M mRNA) is readily spliced. The ratio of M1 encoded by a spliced M mRNA to CM2 encoded by an unspliced M mRNA in influenza C virus-infected cells was about 10 times larger than that in M gene-transfected cells, suggesting that a viral protein(s) other than M gene translational products facilitates viral mRNA splicing. RNase protection assays showed that the splicing of M mRNA in infected cells was much higher than that in M gene-transfected cells. The unspliced and spliced mRNAs of the influenza C virus NS gene encode two nonstructural (NS) proteins, NS1(C/NS1) and NS2(C/NS2), respectively. The introduction of premature translational termination into the NS gene, which blocked the synthesis of the C/NS1 and C/NS2 proteins, drastically reduced the splicing of NS mRNA, raising the possibility that C/NS1 or C/NS2 enhances viral mRNA splicing. The splicing of influenza C virus M mRNA was increased by coexpression of C/NS1, whereas it was reduced by coexpression of the influenza A virus NS1 protein (A/NS1). The splicing of influenza A virus M mRNA was also increased by coexpression of C/NS1, though it was inhibited by that of A/NS1. These results suggest that influenza C virus NS1, but not A/NS1, can upregulate viral mRNA splicing.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009982 Gammainfluenzavirus A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to types A and B but less common, more stable, more homogeneous, and lacking the neuraminidase protein. They have not been associated with epidemics but may cause mild influenza. Influenza C virus is the type species. FLUCV,Gammainfluenzavirus influenzae,Influenza C Virus,Influenza Viruses Type C,Influenza virus type C,Influenzavirus C,Orthomyxoviruses Type C,Gammainfluenzaviruses,Influenza C Viruses,Virus, Influenza C
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012326 RNA Splicing The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm. RNA, Messenger, Splicing,Splicing, RNA,RNA Splicings,Splicings, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
September 2010, The Journal of general virology,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
April 1995, Journal of virology,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
August 1994, Genes & development,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
April 1995, The Journal of general virology,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
August 2022, Current opinion in virology,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
August 1986, Proceedings of the National Academy of Sciences of the United States of America,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
February 1994, The EMBO journal,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
May 2010, Journal of immunology (Baltimore, Md. : 1950),
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
October 2017, Journal of molecular biology,
Yasushi Muraki, and Takatoshi Furukawa, and Yoshihiko Kohno, and Yoko Matsuzaki, and Emi Takashita, and Kanetsu Sugawara, and Seiji Hongo
January 2012, The Journal of general virology,
Copied contents to your clipboard!